Pharmacokinetics and Pharmacodynamics of Vildagliptin in Patients with Type 2 Diabetes Mellitus

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.46, Iss.7, 2007-01, pp. : 577-588

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vildagliptin in the treatment of type 2 diabetes mellitus

By Stamataros George Schneider Stephen H

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 12, 2011-08 ,pp. : 1967-1973

Informa Healthcare

Access to resources Recommend Favorite

Comparative Efficacy of Vildagliptin and Sitagliptin in Japanese Patients with Type 2 Diabetes Mellitus: A Matching-Adjusted Indirect Comparison of Randomized Trials

By Signorovitch James E.

Clinical Drug Investigation, Vol. 31, Iss. 9, 2011-09 ,pp. : 665-674

Adis International

Access to resources Recommend Favorite

Vildagliptin improves -cell function in previously untreated patients with type 2 diabetes mellitus

Inpharma, Vol. 1, Iss. 1505, 2005-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Vildagliptin: A Review of its Use in Type 2 Diabetes Mellitus

By Keating Gillian M.

Drugs, Vol. 70, Iss. 16, 2010-11 ,pp. : 2089-2112

Adis International

Access to resources Recommend Favorite

Combination therapy with metformin plus vildagliptin in type 2 diabetes mellitus

By Guarino Elisa Nigi Laura Patti Aurora Fondelli Cecilia Dotta Francesco

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 9, 2012-06 ,pp. : 1377-1384

Informa Healthcare

Access to resources Recommend Favorite